Harvey Che

Institute of Cancer Research

*This is an algorithmically generated author record based on publicly available information.

See Latest Publications

See Most Cited Publications

ORCID Profile

Google Scholar

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Institute of Cancer Research

Research Subjects

Research Interests

Harvey Che has a total of 34 co-authors. Here are the top co-authors by number of shared publications:

Alexandra Saint-Charles
Institut Curie 4 INSERM U1330, Childhood Oncology Research Unit (CONCERT) Paris, France
39 shared publications
Angel Montero Carcaboso
SJD Pediatric Cancer Center Barcelona, Hospital Sant Joan de Deu, Institut de Recerca Sant Joan de Deu (IRSJD), Barcelona, Spain
39 shared publications
Angela Bellini
SiRIC RTOP (Recherche Translationelle en Oncologie Pediatrique), U830 INSERM and SIREDO Integrated Pediatric Oncology Center, Institut Curie, 26 Rue d'Ulm, 75005, Paris, France
39 shared publications
Angharad Goodman
Newcastle Genetics Laboratory, Newcastle upon Tyne Hospitals NHS Trust, Newcastle upon Tyne, United Kingdom
39 shared publications
Barbara Martins Da Costa
Institute of Cancer Research 5
39 shared publications
Birgit Geoerger
Department of Pediatric and Adolescent Oncology, Gustave Roussy, Université Paris-Saclay, Villejuif, France
39 shared publications

Latest Publications

Sort by

Open Access
Website
Google Scholar
- 25 November 2025
- Published by American Association for Cancer Research (AACR)
Figure S3 from Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models
by Elizabeth R. Tucker, Irene Jiménez, Lindi Chen, Angela Bellini, Chiara Gorrini, Elizabeth Calton, Qiong Gao, Harvey Che, Evon Poon, Yann Jamin, et al.
Website
Google Scholar
- 25 November 2025
- Published by American Association for Cancer Research (AACR)
Open Access
Figure S3 from Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models
by Elizabeth R. Tucker, Irene Jiménez, Lindi Chen, Angela Bellini, Chiara Gorrini, Elizabeth Calton, Qiong Gao, Harvey Che, Evon Poon, Yann Jamin, et al.
Open Access
Website
Google Scholar
- 25 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Data DS1 from Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models
by Elizabeth R. Tucker, Irene Jiménez, Lindi Chen, Angela Bellini, Chiara Gorrini, Elizabeth Calton, Qiong Gao, Harvey Che, Evon Poon, Yann Jamin, et al.
Supplementary methods, supplementary tables, supplementary figure legends
Website
Google Scholar
- 25 November 2025
- Published by American Association for Cancer Research (AACR)
Open Access
Supplementary Data DS1 from Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models
by Elizabeth R. Tucker, Irene Jiménez, Lindi Chen, Angela Bellini, Chiara Gorrini, Elizabeth Calton, Qiong Gao, Harvey Che, Evon Poon, Yann Jamin, et al.
Supplementary methods, supplementary tables, supplementary figure legends
Open Access
Website
Google Scholar
- 25 November 2025
- Published by American Association for Cancer Research (AACR)
Figure S5 from Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models
by Elizabeth R. Tucker, Irene Jiménez, Lindi Chen, Angela Bellini, Chiara Gorrini, Elizabeth Calton, Qiong Gao, Harvey Che, Evon Poon, Yann Jamin, et al.
Website
Google Scholar
- 25 November 2025
- Published by American Association for Cancer Research (AACR)
Open Access
Figure S5 from Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models
by Elizabeth R. Tucker, Irene Jiménez, Lindi Chen, Angela Bellini, Chiara Gorrini, Elizabeth Calton, Qiong Gao, Harvey Che, Evon Poon, Yann Jamin, et al.
Open Access
Website
Google Scholar
- 25 November 2025
- Published by American Association for Cancer Research (AACR)
Figure S2 from Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models
by Elizabeth R. Tucker, Irene Jiménez, Lindi Chen, Angela Bellini, Chiara Gorrini, Elizabeth Calton, Qiong Gao, Harvey Che, Evon Poon, Yann Jamin, et al.
Website
Google Scholar
- 25 November 2025
- Published by American Association for Cancer Research (AACR)
Open Access
Figure S2 from Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models
by Elizabeth R. Tucker, Irene Jiménez, Lindi Chen, Angela Bellini, Chiara Gorrini, Elizabeth Calton, Qiong Gao, Harvey Che, Evon Poon, Yann Jamin, et al.
Open Access
Website
Google Scholar
- 25 November 2025
- Published by American Association for Cancer Research (AACR)
Figure S6 from Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models
by Elizabeth R. Tucker, Irene Jiménez, Lindi Chen, Angela Bellini, Chiara Gorrini, Elizabeth Calton, Qiong Gao, Harvey Che, Evon Poon, Yann Jamin, et al.
Cell line growth curves and PDX data for idasanutlin combination
Website
Google Scholar
- 25 November 2025
- Published by American Association for Cancer Research (AACR)
Open Access
Figure S6 from Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models
by Elizabeth R. Tucker, Irene Jiménez, Lindi Chen, Angela Bellini, Chiara Gorrini, Elizabeth Calton, Qiong Gao, Harvey Che, Evon Poon, Yann Jamin, et al.
Cell line growth curves and PDX data for idasanutlin combination
Open Access
Website
Google Scholar
- 25 November 2025
- Published by American Association for Cancer Research (AACR)
Figure S1 from Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models
by Elizabeth R. Tucker, Irene Jiménez, Lindi Chen, Angela Bellini, Chiara Gorrini, Elizabeth Calton, Qiong Gao, Harvey Che, Evon Poon, Yann Jamin, et al.
Website
Google Scholar
- 25 November 2025
- Published by American Association for Cancer Research (AACR)
Open Access
Figure S1 from Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models
by Elizabeth R. Tucker, Irene Jiménez, Lindi Chen, Angela Bellini, Chiara Gorrini, Elizabeth Calton, Qiong Gao, Harvey Che, Evon Poon, Yann Jamin, et al.
Open Access
Website
Google Scholar
- 25 November 2025
- Published by American Association for Cancer Research (AACR)
Figure S4 from Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models
by Elizabeth R. Tucker, Irene Jiménez, Lindi Chen, Angela Bellini, Chiara Gorrini, Elizabeth Calton, Qiong Gao, Harvey Che, Evon Poon, Yann Jamin, et al.
Website
Google Scholar
- 25 November 2025
- Published by American Association for Cancer Research (AACR)
Open Access
Figure S4 from Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models
by Elizabeth R. Tucker, Irene Jiménez, Lindi Chen, Angela Bellini, Chiara Gorrini, Elizabeth Calton, Qiong Gao, Harvey Che, Evon Poon, Yann Jamin, et al.
Open Access
Website
Google Scholar
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Figure S3 from Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models
by Elizabeth R. Tucker, Irene Jiménez, Lindi Chen, Angela Bellini, Chiara Gorrini, Elizabeth Calton, Qiong Gao, Harvey Che, Evon Poon, Yann Jamin, et al.
Website
Google Scholar
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Open Access
Figure S3 from Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models
by Elizabeth R. Tucker, Irene Jiménez, Lindi Chen, Angela Bellini, Chiara Gorrini, Elizabeth Calton, Qiong Gao, Harvey Che, Evon Poon, Yann Jamin, et al.
Open Access
Website
Google Scholar
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Figure S3 from Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models
by Elizabeth R. Tucker, Irene Jiménez, Lindi Chen, Angela Bellini, Chiara Gorrini, Elizabeth Calton, Qiong Gao, Harvey Che, Evon Poon, Yann Jamin, et al.
Website
Google Scholar
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Open Access
Figure S3 from Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models
by Elizabeth R. Tucker, Irene Jiménez, Lindi Chen, Angela Bellini, Chiara Gorrini, Elizabeth Calton, Qiong Gao, Harvey Che, Evon Poon, Yann Jamin, et al.
Open Access
Website
Google Scholar
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Data DS1 from Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models
by Elizabeth R. Tucker, Irene Jiménez, Lindi Chen, Angela Bellini, Chiara Gorrini, Elizabeth Calton, Qiong Gao, Harvey Che, Evon Poon, Yann Jamin, et al.
Supplementary methods, supplementary tables, supplementary figure legends
Website
Google Scholar
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Open Access
Supplementary Data DS1 from Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models
by Elizabeth R. Tucker, Irene Jiménez, Lindi Chen, Angela Bellini, Chiara Gorrini, Elizabeth Calton, Qiong Gao, Harvey Che, Evon Poon, Yann Jamin, et al.
Supplementary methods, supplementary tables, supplementary figure legends

Show all